This might be due to the fact that quiescent CML LSCs do not have an absolute requirement for BCR-ABL1 tyrosine kinase activity for their survival and self-renewal, although this is a controversial aspect [103,104]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.